Platelet activation induced by a murine monoclonal antibody directed against a novel tetra-span antigen.
MAb 14A2.H1 identifies a novel low-abundance platelet surface antigen, PETA-3, which is a member of the tetra-span (TM4) family. This MAb brings about platelet aggregation and mediator release, which is completely inhibitable by prostaglandin E1, and partially inhibitable by aspirin and ketanserin. Platelet activation by MAb 14A2.H1 is dependent on interaction with both the platelet Fc receptor, Fc gamma RII, and the specific antigen as it was prevented by either a blocking MAb to Fc gamma RII (IV.3) or F(ab')2 fragments of 14A2.H1. The extent of platelet activation by the antibody varied considerably between donors, and is believed to reflect the polymorphism of Fc gamma RII. Subaggregating concentrations of 14A2.H1 synergized with other platelet agonists, ADP, adrenaline, collagen and serotonin, indicating signalling via a pathway distinct from these activators. Synergy was also blocked by MAb IV.3, or F(ab')2 fragments of 14A2.H1. The similar low copy number of PETA-3 and Fc gamma RII in the platelet membrane (approximately 1000/platelet), together with the dependence on Fc gamma RII for activation by MAb 14A2.H1, suggests that PETA-3 may be a component of the Fc gamma RII signal transducing complex in platelets.
Roberts
J J
JJ
Department of Clinical and Experimental Pharmacology, University of Adelaide, South Australia.
Rodgers
S E
SE
Drury
J
J
Ashman
L K
LK
Lloyd
J V
JV
D000244:Adenosine Diphosphate / Q000494:pharmacology; D000911:Antibodies, Monoclonal / Q000276:immunology*; D001241:Aspirin / Q000494:pharmacology; D004305:Dose-Response Relationship, Drug; D006801:Humans; D010974:Platelet Aggregation / Q000276:immunology*; D010980:Platelet Membrane Glycoproteins / Q000276:immunology*; D017452:Receptors, IgG / Q000276:immunology*
D000911:Antibodies, Monoclonal; D010980:Platelet Membrane Glycoproteins; D017452:Receptors, IgG; D000244:Adenosine Diphosphate; D001241:Aspirin